Patents by Inventor Kate Nuwaysir

Kate Nuwaysir has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8892365
    Abstract: The present invention provides methods for optimizing oligonucleotide hybridization probes for use in basic and clinical research. Specifically, the invention involves hybridizing serially diluted genomic sample to the oligonucleotide probes on the array, such that a signal intensity is produced for each of the probes; computationally identifying optimized probes which exhibit signal intensities that correspond to the serial dilutions of genomic sample and are reproducibly strong relative to non-optimized probes.
    Type: Grant
    Filed: February 14, 2013
    Date of Patent: November 18, 2014
    Assignee: Ventana Medical Systems, Inc.
    Inventors: Todd Richmond, Jason Norton, Emile F. Nuwaysir, Roland Green, Kate Nuwaysir
  • Publication number: 20140031244
    Abstract: The present invention provides methods for optimizing oligonucleotide hybridization probes for use in basic and clinical research. Specifically, the invention involves hybridizing serially diluted genomic sample to the oligonucleotide probes on the array, such that a signal intensity is produced for each of the probes; computationally identifying optimized probes which exhibit signal intensities that correspond to the serial dilutions of genomic sample and are reproducibly strong relative to non-optimized probes.
    Type: Application
    Filed: February 14, 2013
    Publication date: January 30, 2014
    Inventors: Todd Richmond, Jason Norton, Emile F. Nuwaysir, Roland Green, Kate Nuwaysir
  • Publication number: 20110153222
    Abstract: The present invention provides methods for optimizing oligonucleotide hybridization probes for use in basic and clinical research. Specifically, the invention involves hybridizing serially diluted genomic sample to the oligonucleotide probes on the array, such that a signal intensity is produced for each of the probes; computationally identifying optimized probes which exhibit signal intensities that correspond to the serial dilutions of genomic sample and are reproducibly strong relative to non-optimized probes.
    Type: Application
    Filed: December 8, 2010
    Publication date: June 23, 2011
    Applicant: Roche Nimblegen, Inc.
    Inventors: Todd Richmond, Jason Norton, Emile F. Nuwaysir, Roland Green, Kate Nuwaysir
  • Patent number: 7869959
    Abstract: The present invention provides methods for optimizing oligonucleotide hybridization probes for use in basic and clinical research. Specifically, the invention involves hybridizing serially diluted genomic sample to the oligonucleotide probes on the array, such that a signal intensity is produced for each of the probes; computationally identifying optimized probes which exhibit signal intensities that correspond to the serial dilutions of genomic sample and are reproducibly strong relative to non-optimized probes.
    Type: Grant
    Filed: February 3, 2006
    Date of Patent: January 11, 2011
    Assignee: Roche Nimblegen, Inc.
    Inventors: Todd Richmond, Jason Norton, Emile F. Nuwaysir, Roland Green, Kate Nuwaysir
  • Publication number: 20060177858
    Abstract: The present invention provides methods for optimizing oligonucleotide hybridization probes for use in basic and clinical research. Specifically, the invention involves hybridizing serially diluted genomic sample to the oligonucleotide probes on the array, such that a signal intensity is produced for each of the probes; computationally identifying optimized probes which exhibit signal intensities that correspond to the serial dilutions of genomic sample and are reproducibly strong relative to non-optimized probes.
    Type: Application
    Filed: February 3, 2006
    Publication date: August 10, 2006
    Inventors: Todd Richmond, Jason Norton, Emile Nuwaysir, Roland Green, Kate Nuwaysir